關於 台灣 recruitment agency ，我們在網路上蒐集到這些相關的討論、資訊與評價

2021首PO 來聊聊我的海外求職之心路歷程

前情提要…去年底拿到"就業英語證照"，並完成金融證照的第一科(共三科)，想想應該來試試看找些金融相關的工作，但沒想到投了20幾個金融職缺，竟然沒有得到任何面試機會…重點"沒有得到任何面試機會"，不是不錄用，是"沒有任何面試機會" (按，這是我從來想有想過的事)。

前後有三個recruitment agency跟我聯絡，共同結論就是，他們覺得我的經歷看起來很不錯，很想幫我找資深一點的職位，但現實面卻是: 不論妳經歷有多漂亮，金融業經驗多長，沒有當地經驗在這邊就是零。好啊~ 那我從零開始嘛，我從entry level開始總行了吧! ㄟ~ 還是不行歐~ 市場上有那麼多社會新鮮人便宜又好使喚，為什麼要用妳這個"有經驗的"又"可能叫不動的"老菜鳥。 靠~ 所以我到底是有經驗，還是沒經驗啦!!! Anyway...我的求職路就是一個鬼打牆…。

那到底怎麼解…

除非，有人強烈推薦妳，對方又appreciate妳的海外經驗，不介意妳人脈還不夠廣，願意讓妳邊學邊作，教妳指導妳訓練妳⋯這聽起來就是中樂透的情境啊!

朋友說，妳就放寬心顧好小孩，讓J去賺錢就好啦! 不可諱言，我一開始確實是這麼想，但我發現我要的並不是錢這麼簡單。我須要的是一個認同感，一個可以發揮所長、展現自我的舞台…

就這樣…一邊心煩著就算拿到金融證照還是沒有當地經驗，另一邊還是繼續完成金融證照第二科…

結果:

我…竟…然…真…得…中…樂…透…了~

託老J的福，靠著老J上司的關系，我得到一個金融公司的面試機會，公司真得願意讓我在還沒完成金融證照前，先到公司邊作邊學，還要送我去合作的銀行培訓…這真的是一個意外的驚喜!!!
沒意外的話，未來幾年我會專注在貸款業務上(不是高利貸，不要誤會)，從房屋貸款、商業貸款、建築貸款到開發貸款，我都有機會涉獵，未來我就會成為一個專業的mortgage broker 或 mortgage adviser。

雖然，跟過去的專業不相關…但在這裡，我需要的就是一個敲門磚…所以莎莎距離獨立自主新女性又更進一步啦!

BTW，這裡的金融就業市場跟台灣真的很不一樣。
大部份的業務工作都是commission based，公司和你是合作關系而不是聘僱關系。因此，公司不會付你底薪，而且你會須要成立自己的company(像sole trader但是是limited company structure)，才可以跟公司簽合作契約，然後獨立報帳報稅和退稅（有點像台灣在講的靠行）。看起來，好像很多事要自己來，但這個妳所依靠的公司其實仍然扮演非常重要的角色，除了內部中後台資源、教育訓練、經驗分享和指導外，也因為有公司，我才有機會接觸到潛在客戶群和大型銀行及貸放款機構。
於是，本人也成立了一間自己的公司- SCG。申請過程有點緊張，但天哪，紐西蘭真的是全世界最容易成立公司的國家了。我前後花不到24小時就完成申請，不用資本額，不用公司章程什麼的…只須要有自己的稅號就可以設立一間公司了。而且我slogan都想好了…

"Supreme Capital，the best funding Gateway"

紐西蘭的朋友們~ 之後請記得:
貸款找莎莎
買房買地找老J

謝謝收看

【外國居民訂車票、網路購物、醫療掛號不再卡卡！】
#新式外來居留人口統一證號 110年1月
正！式！上！路！

外國朋友歷年來時常透過歐洲在台商會以及美國商會等團體，表達統一證號使用上的不便。

國發會為此與內政部移民署及相關各部會協調多時，
終於將自110年1月2日起，核發載有新式外來人口統一證號的證件👍

新式證號將比照國人的身分證號，開頭的兩碼編碼將由兩個英文字母，改成「與台灣人一樣的」一個英文字母、一個數字。
不但降低各種困擾，並增加對我國的歸屬感，外國朋友也能夠順暢地進行各類 #網路購物、 #訂票、 #醫療掛號 等與日常生活息息相關的各項服務🙌

為使外國人更融入台灣生活，國發會過去建置外僑居留證使用問題的解決平臺，也修正相關法規使外僑居留證與外國護照有同等的法律效力等，解決外僑居留證各類問題，近2年再經多次會議，爭取經費及協調辦理。

國發會亦將持續推動 #雙語國家政策 及 #攬才留才政策 等
加強打造友善環境，提升外國朋友在台歸屬感，營造我國成為全球人才匯聚中心！

📍Introduction to the New UI No. of Foreign Nationals
➪ https://youtu.be/-6qCkzeV8AM

#新式外來人口統一證號 #友善外國人生活 #攬才

--------------------------------------

【No more impediments for foreign residents using an ARC to book transport, shop online, or register to see a doctor!】

January 2021 brings the official launch of a new UI No. format for foreign residents!

In the past, foreign friends have often been vexed by inconveniences stemming from the UI No. format of ARCs, as has been communicated to the government through the ECCT, AmCham, and other organizations. The NDC has held multiple consultations with the National Immigration Agency and other relevant agencies on achieving a solution to this problem. Now, at last, from January 2, 2021, the problem will be solved by the issuance of a new UI No. format for resident permits!

The new UI No. format matches the national ID card number format. Instead of beginning with two English letters, it starts with a single English letter followed by a nine-digit number, the same as citizen ID cards. Apart from removing all kinds of difficulties for foreign residents, it will also give them a stronger sense of belonging in Taiwan. The new UI No. can be used without a hitch to utilize all kinds of everyday services such as booking seats on public transport, buying things online, making medical appointments, and more.

The NDC has made a strong commitment to helping foreigners fit into life in Taiwan. Besides setting up a platform for addressing problems relating to the use of ARCs, it has also orchestrated the amendment of various regulations to provide ARCs with the same legal validity as foreign passports for the purpose of identifying the holder. The NDC has also held numerous meetings over the past two years to secure funding and coordinate solutions to problems of ARC utility.

The NDC will continue promoting the bilingual nation policy along with measures for talent recruitment and retention, to create a welcoming environment, give foreign friends a heightened sense of belonging in Taiwan, and make our country a gathering hub for talent from around the world!

#New UI No. format #Foreigner-friendly #Talent recruitment

【International Live Webinar Series】Strategies for Applying Clinical Trials in Europe歐洲臨床試驗申請策略與佈局

🌍此次學苑特別推出國際線上同步遠距課程，並與德國講師合作，提供學員最新的國際臨床試驗實務課程!
此次課程為系列課程，首堂為”歐洲臨床試驗申請策略與佈局”。對於想往歐洲發展、合作或與歐洲從事臨床試驗的相關公司廠商有很大的幫助!

Date:
Part 1: 2020/12/01 (Tues) 16:30 ~ 18:00 (GMT+8)
Part 2: 2020/12/03 (Thurs) 16:30 ~ 18:00 (GMT+8)
Location：Online Webinar Training
Instructor：Anika Staack, Founder of ARC-TRAICOA / EU-QPPV
【Course Outline】
Part 1 2020/12/01 (Tues) 16:30 ~ 18:00 (GMT+8)
A. Europe – One Union with differences

B. European Clinical Trial Directive
1.Role of national competent authorities
2.Role of ethics committees (central / local)
3.Role of investigator
4.Role of sponsor
5.Role of EMA

C. Planning clinical trials in Europe
1.Analysis of product
a.Indication
b.Patient group
2.Analysis of end points
3 .Analysis of protocol
4.Preparing feasibility
5.Choosing Key Opinion Leaders
6.Sponsor or IIT?
7.Similar studies already running?

Part 2 2020/12/03 (Thurs) 16:30 ~ 18:00 (GMT+8)
A. Applying clinical trial
1.Collecting information you need
2.Establishing study team

B. Required entry into EudraCT

C. Required approval from national HAs and ethics

D. Required fulfilment of national data protection laws

E. Considerations
1.Doing it by yourselves
2.Contracting CRO
3.Auditing

F. Upcoming issues: Site and patient recruitment, site resources, patients withdrawal, protocol amendments

G. Final presentation of study reports

Online Course Fees include 2 Webinars, 90 minutes each：
Special Price $160 USD per Person; Original Price $180 USD
(*1) Certificate of Attendance will be issued only if participants attend both part 1 & 2 webinar
(*2) Certificate of Completed Assessment will be issued only if participant pass the assessment

Register here 👉 https://forms.gle/Kj9yMVynsq7yzSzs8

Organizer：ARC-TRAICOA
Co-Organizer：Salt and Light Institute

【Target Audience】
(1.) Anyone who is interested in clinical trials in Europe
(2.) Anyone who has experience in working in clinical trials related field such as PI,PM,RA,RD,MA,DM,ST,CRA, CRC,QC,QA, etc)

【Instructor CV】
Anika Staack

Current Position:
Founder of ARC-TRAICOA
EU-Qualified Person for Pharmacovigilance (EU-QPPV)
Local German QPPV Consultant and Speaker

Previous Experience:
EU-QPPV / Stufenplanbeauftragte & Group Leader PV at Medice
Senior Drug Safety Manager at ICON
Lead Site Management Associate at PRA
Clinical Research Associate at SKM Oncology

Expertise:
Expertise Databases: European Medicine Agency EudraVigilance and xEVMPD
Quality Assurance: Audits & Inspections, SOP Writing and QA documentation, recalls and product quality
Clinical Trial Management: Feasibility, monitoring, eCRF set-up, database reconciliation, site selection, contract management, patient recruitment, study reports
Authorization process: PSMF, RMP & PSUR Writing, answering authority requests, Risk Management, overseeing product life-cycle

Education Background:
Master of Science (Biology)

Email: bioschool@biotech-edu.com Tel: (+886) 02-2545-9721 ext.18